Neuritek Therapeutics
New York · Founded 2017
About Neuritek Therapeutics
Neuritek Therapeutics is a biopharmaceutical company focused on developing innovative treatments for mental health disorders, particularly post-traumatic stress disorder (PTSD). The company aims to revolutionize mental health treatment by addressing the root causes of psychiatric conditions. Neuritek is committed to creating therapies that have the potential to transform the lives of patients and families affected by these disorders. Their research and development efforts are centered on next-generation therapies that could significantly impact the field of mental health care.
Company Facts
- Founded: 2017
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Website: https://www.neuritek.com
- Phone: +1 212 956 2004
Industries & Categories
Clinical Trials, Health Care, Mental Health, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/neuritek-therapeutics-3047053 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.